<HashMap><database>biostudies-literature</database><scores/><additional><submitter>van den Boogaard ML</submitter><funding>ZonMW Vidi grant</funding><funding>European Research Council</funding><funding>Villa Joep Foundation</funding><funding>ZonMw</funding><funding>Stichting Kinderen Kankervrij</funding><funding>Oncode Institute</funding><funding>Dutch Cancer Society (KWF)/Alpe d&amp;apos;HuZes Bas Mulder Award</funding><pagination>e2007898118</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8433536</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>118(36)</volume><pubmed_abstract>Neuroblastomas are childhood tumors with frequent fatal relapses after induction treatment, which is related to tumor evolution with additional genomic events. Our whole-genome sequencing data analysis revealed a high frequency of somatic cytosine > adenine (C > A) substitutions in primary neuroblastoma tumors, which was associated with poor survival. We showed that increased levels of C > A substitutions correlate with copy number loss (CNL) of &lt;i>OGG1&lt;/i> or &lt;i>MUTYH&lt;/i> Both genes encode DNA glycosylases that recognize 8-oxo-guanine (8-oxoG) lesions as a first step of 8-oxoG repair. Tumor organoid models with CNL of &lt;i>OGG1&lt;/i> or &lt;i>MUTYH&lt;/i> show increased 8-oxoG levels compared to wild-type cells. We used CRISPR-Cas9 genome editing to create knockout clones of &lt;i>MUTYH&lt;/i> and &lt;i>OGG</pubmed_abstract><journal>Proceedings of the National Academy of Sciences of the United States of America</journal><pubmed_title>Defects in 8-oxo-guanine repair pathway cause high frequency of C > A substitutions in neuroblastoma.</pubmed_title><pmcid>PMC8433536</pmcid><funding_grant_id>91716482</funding_grant_id><funding_grant_id>N/A</funding_grant_id><funding_grant_id>10218</funding_grant_id><pubmed_authors>van Gerven MR</pubmed_authors><pubmed_authors>van Boxtel R</pubmed_authors><pubmed_authors>Zwijnenburg DA</pubmed_authors><pubmed_authors>Essing AHW</pubmed_authors><pubmed_authors>Koster J</pubmed_authors><pubmed_authors>Hakkert A</pubmed_authors><pubmed_authors>Schild L</pubmed_authors><pubmed_authors>Drost J</pubmed_authors><pubmed_authors>van den Boogaard ML</pubmed_authors><pubmed_authors>Ebus ME</pubmed_authors><pubmed_authors>Hoyng LL</pubmed_authors><pubmed_authors>Dolman MEM</pubmed_authors><pubmed_authors>Koopmans B</pubmed_authors><pubmed_authors>Molenaar JJ</pubmed_authors><pubmed_authors>Helleday T</pubmed_authors><pubmed_authors>Versteeg R</pubmed_authors><pubmed_authors>Oka R</pubmed_authors><pubmed_authors>Molenaar P</pubmed_authors></additional><is_claimable>false</is_claimable><name>Defects in 8-oxo-guanine repair pathway cause high frequency of C > A substitutions in neuroblastoma.</name><description>Neuroblastomas are childhood tumors with frequent fatal relapses after induction treatment, which is related to tumor evolution with additional genomic events. Our whole-genome sequencing data analysis revealed a high frequency of somatic cytosine > adenine (C > A) substitutions in primary neuroblastoma tumors, which was associated with poor survival. We showed that increased levels of C > A substitutions correlate with copy number loss (CNL) of &lt;i>OGG1&lt;/i> or &lt;i>MUTYH&lt;/i> Both genes encode DNA glycosylases that recognize 8-oxo-guanine (8-oxoG) lesions as a first step of 8-oxoG repair. Tumor organoid models with CNL of &lt;i>OGG1&lt;/i> or &lt;i>MUTYH&lt;/i> show increased 8-oxoG levels compared to wild-type cells. We used CRISPR-Cas9 genome editing to create knockout clones of &lt;i>MUTYH&lt;/i> and &lt;i>OGG</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Sep</publication><modification>2026-05-08T16:39:21.976Z</modification><creation>2025-06-01T00:57:18.491Z</creation></dates><accession>S-EPMC8433536</accession><cross_references><pubmed>34479993</pubmed><doi>10.1073/pnas.2007898118</doi></cross_references></HashMap>